Anna-Lena Spetz
Fondateur chez TIRmed Pharma AB
Profil
Anna-Lena Spetz is the founder of TIRmed Pharma AB, which was founded in 2018, where she holds the title of Chief Executive Officer & Director.
Currently, Dr. Spetz holds the title of Professor at both the Centre for Infectious Medicine and Karolinska University Hospital.
Dr. Spetz's former positions include Director at Avaris AB, and Principal at Harvard University, Institut Pasteur, and the University of Stockholm.
Postes actifs de Anna-Lena Spetz
| Sociétés | Poste | Début |
|---|---|---|
| Centre for Infectious Medicine | Corporate Officer/Principal | 02/06/2010 |
Karolinska University Hospital
 Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Corporate Officer/Principal | 02/06/2010 |
TIRmed Pharma AB
 TIRmed Pharma AB Pharmaceuticals: MajorHealth Technology TIRmed Pharma AB is engaged in pharmacy services. The company was founded by Jan-Erik Nystroem and Anna-Lena Spetz in 2018 and is headquartered in Bromma, Sweden. | Fondateur | 01/01/2018 |
Anciens postes connus de Anna-Lena Spetz
| Sociétés | Poste | Fin |
|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| University of Stockholm | Corporate Officer/Principal | - |
Institut Pasteur
 Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Corporate Officer/Principal | - |
Avaris AB
 Avaris AB Miscellaneous Commercial ServicesCommercial Services Avaris was founded in 2001 by research teams at the Karolinska Institute and Karolinska Innovations AB. The company is based on four proprietary technology platforms within cell and gene therapy. Avaris drives the research development and commercialization of new therapies in close collaboration with the founders, research teams, and strategic partners. The company is well positioned in cell and gene therapy field for chronic infections, cancer and inherited diseases. Avaris vision is to become the number one supplier of individualized cell and gene therapy treatments in northern Europe. In order to reach this goal it is exploring possibilities to acquire, or in license cell therapy technologies that complement the in house growth. Avaris is also open to partnering possibilities. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Miscellaneous |
Avaris AB
Avaris AB Miscellaneous Commercial ServicesCommercial Services Avaris was founded in 2001 by research teams at the Karolinska Institute and Karolinska Innovations AB. The company is based on four proprietary technology platforms within cell and gene therapy. Avaris drives the research development and commercialization of new therapies in close collaboration with the founders, research teams, and strategic partners. The company is well positioned in cell and gene therapy field for chronic infections, cancer and inherited diseases. Avaris vision is to become the number one supplier of individualized cell and gene therapy treatments in northern Europe. In order to reach this goal it is exploring possibilities to acquire, or in license cell therapy technologies that complement the in house growth. Avaris is also open to partnering possibilities. | Commercial Services |
| Centre for Infectious Medicine | |
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Health Services |
TIRmed Pharma AB
TIRmed Pharma AB Pharmaceuticals: MajorHealth Technology TIRmed Pharma AB is engaged in pharmacy services. The company was founded by Jan-Erik Nystroem and Anna-Lena Spetz in 2018 and is headquartered in Bromma, Sweden. | Health Technology |
